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A B S T R A C T
Porcupine bezoar (PB) is a calciﬁed undigested material generally found in porcupine’s (Hystrix brachyura)
gastrointestinal tract. The bezoar is traditionally used in South East Asia and Europe for the treatment of cancer,
poisoning, dengue, typhoid, etc. However, limited scientiﬁc studies have been performed to verify its anticancer
potential to substantiate its traditional claims in the treatment of cancers. Hence, this study was aimed at in-
vestigating the in vitro and in vivo anticancer properties of two grassy PB aqueous extract (PB-A and PB-B) using
A375 cancer cell line and zebraﬁsh model, respectively. This paper presents the ﬁrst report on in vitro A375 cell
viability assay, apoptosis assay, cell cycle arrest assay, migration assay, invasion assay, qPCR experimental assay
and in vivo anti-angiogenesis assay using the grassy PBs. Experimental ﬁndings revealed IC50 value are
26.59 ± 1.37 μg/mL and 30.12 ± 3.25 μg/mL for PB-A and PB-B respectively. PBs showed anti-proliferative
activity with no signiﬁcant cytotoxic eﬀect on normal human dermal ﬁbroblast (NHDF). PBs were also found to
induce apoptosis via intrinsic pathway and arrest cell cycle at G2/M phase. Additionally, the ﬁndings indicated
its ability to debilitate migration and invasion of A375 cells. Further evaluation using embryo zebraﬁsh model
revealed LC50= 450.0 ± 2.50 μg/mL and 58.7 ± 5.0 μg/mL for PB-A and PB-B which also exerted anti-an-
giogenesis eﬀect in zebraﬁsh. Moreover, stearic acid, ursodeoxycholic acid and pregnenolone were identiﬁed as
possible metabolites that might contribute to the anticancer eﬀect of the both PBs. Overall, this study demon-
strated that PB-A and PB-B possess potential in vitro and in vivo anticancer eﬀects which are elicited through
selective cytotoxic eﬀect, induction of apoptosis, inhibition of migration and invasion and anti-angiogenesis.
This study provides scientiﬁc evidence that the porcupine bezoar do possess anti-cancer eﬃcacy and further
justiﬁes its traditional utility. However, more experiments with higher vertebrae models are still warranted to
validate its traditional claims as an anticancer agent.
1. Introduction
Natural resources as remedies for medicinal purposes are common
in human history. Plant and animals are used as main sources not just
for food but also as medicine to cure disease or illness. Moreover, for
decades, natural products from plant and animal have been the active
ingredient for medicine. In fact 60% of approved anticancer drugs have
been isolated or derived from natural resources [1]. Notwithstanding
synthetic chemopreventive and anticancer agents are extensively
available, drugs obtained from natural products have been reported to
demonstrate promising results as well [2]. Presently, extensive research
studies have been carried out worldwide to isolate more active and safe
bioactive agents including anticancer agents from natural resources
including plant, microbes, marine and animals [3,4].
Malignant melanoma is one of the most fatal skin cancers as report
in 2016 stated melanoma as 3rd most prevalence cancer in the United
State of America for male and 5th for female [5]. Though it can be
cured by surgical removal in early stages, once it is developed into
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metastatic stage, medication becomes extremely diﬃcult as it does not
eﬀectively respond to available therapies [6,7]. Melanoma is an ex-
tremely aggressive disease with high metastatic potential and a notor-
iously high resistance to cytotoxic agents. This is thought to be due to
the fact that melanocytes originate from highly motile cells that have
enhanced survival properties [8]. It is the worst type of skin cancer with
increasing incidence compared to other type of cancers [9]. Malignant
melanoma consists of four major histological subtypes frequently re-
ported namely superﬁcial spreading melanoma (70%), nodular mela-
noma (15%), lentigo maligna melanoma (13%), and acral lentiginous
melanoma (2–3%) [9]. Additionally, it has highest metastatic potential
compared to other skin cancers 10–15% occurring in patients [10].
Furthermore, study revealed patients with metastatic melanoma had
poor prognosis with survival rate of 6–8 months only [11]. Malignant
melanoma has shown poor response to current therapy with signiﬁcant
toxicity and survival depending on types of treatment [5,6]. Thus, the
urgency to ﬁnd a new alternative for melanoma illness countermeasure
is compelling.
In this study, bezoar a natural product obtained from Hystrix bra-
chyura (porcupine) is revealed as potential anticancer agent. Porcupine
bezoars (phytobezoars) are concretions of undigested plants material
that accumulate and calciﬁed in the form of stone within the gastro-
intestinal tract of porcupine [12]. The word bezoar itself origins in
Persian (pad= to expel, zahr= poison) or antidotes [13]. The earliest
documented usage of porcupine bezoar has been mentioned in the
materia medica of Abu Mansur Muwaﬀak in the tenth century [13]. The
Arabic physicians and crusaders spread it to Europe and other countries
as well and by twelfth centuries the bezoars had become widespread
use to treat various diseases in western countries [14]. Further litera-
ture showed that bezoar had been considered as luxury medicinal item
in South East Asian and Europe in 17th century [13,15,16]. The por-
cupine bezoar used to be frequently presented as gift to royalties and
aristocrats due to its rarity and medicinal values [15]. Bezoar is
traditionally believed to possess various medicinal beneﬁts [13,17].
Traditionally, people have been using bezoars to treat deadly diseases
such as cholera, plague, small pox, measles as well as antidotes for
various poisons [12,17,18].
There are reported ancient manuscripts mentioning that bezoars can
be used as an antidotes to counteract various deadly diseases and has
been used as an antidotes for the diseases and medical illness. Thus, we
attempted to evaluate whether PB has similar antidotes properties for
cancer. Hence, the aim of this current research was to investigate the
anticancer activity of porcupine bezoars on the most malignant mela-
noma and further furnish scientiﬁc proof for its mere medicinal asser-
tion as an anticancer agent.
2. Materials and methods
2.1. Chemical and materials
Human melanoma and normal human dermal ﬁbroblast were ob-
tained from American Type Culture Collection (ATCC), USA. Cells were
grown in complete growth medium (CGM) which was made of
Dulbecco’s modiﬁed Eagle medium (DMEM) (Nacalei Tesque, Japan)
supplemented with 10% Fetal Bovine Serum (Nacalei Tesque, Japan) &
1% of Penicillin-Streptomycin (Nacalei Tesque, Japan). Phosphate
buﬀer saline (PBS) (Gibco, USA) was used for cells washing. For ana-
lysing apoptosis and cell cycle, Nexin reagent (Merck Millipore, USA)
and cell cycle reagent (Merck Millipore, USA) were used, respectively.
As for invasion assay, matrigel (CORNING, USA) and crystal violet
(Sigma-Aldrich, USA) were used. For the mRNA expression analysis,
InnuPREP DNA/RNA mini kit (Analytik Jena, Germany), SensiFAST
cDNA synthesis kit (BIOLINE, UK), SensiFAST SYBR® No-ROX Kit
(BIOLINE, USA) and primer (Integrated DNA technologies, Singapore)
were used. 5-Fluorouracil (5-FU) (Sigma, USA), a standard anticancer
drug was used as a positive control. The 3,4- dichloroaniline (3,4-DCA)
Fig. 1. The bezoars used in this study. The PB with Malaysia 50 sen and scale as size reference and the image of PB after being crushed consists of mixture of rough
powder and undigested ﬁbre.a) PB-A, b) PB-B.
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(Sigma, USA), a standard toxic drug was used as a positive control for
embryotoxicity. Paraformaldehyde,methanol, acetone, Tris-base, so-
dium chloride (NaCl), Magnesium chloride (MgCl), Nitro blue tetra-
zolium chloride (NBT) and 5-bromo-4-chloro-3-indolyl phosphate
(BCIP) were purchased from Merck, USA. Tween-20 (ThermoFisher
scientiﬁc,US).
2.2. Porcupine bezoar extracts preparation
Hystrix brachyura (Porcupine) is one of the protected animals ac-
cording to the Malaysian law. Hence, prior to the commencement of
research study, permission was obtained from the Malaysian govern-
ment authority namley, Department of Wildlife and National Parks,
Malaysia for academic and research purposes (JPHL&TN (IP): 100-34/
1.24 Jld 8). The bezoars used in this study are depicted in Fig. 1. The
bezoar colour is mixture of dark green and dark brown, the crushed
bezoars texture are mixture of powder and grass ﬁbre looks. Initially,
the dried grassy porcupine bezoar (PB) (1.09 g) and (8.65 g) were
crushed into powdered form using mortar and pestle. Subsequently,
500mg of powdered grassy PB was extracted using deionized water
with 1:20 ratio for 30min using ultra sonication method to get PB
aqueous extract [19]. The PB aqueous extract were ﬁltered and dried in
an oven at 40 ℃ to obtain the extract in powdered form. The ﬁnal
weight of PB aqueous extract are PB-A (125mg, 25%) and PB-B
(215mg, 45%). The dry powdered form of PB aqueous extracts were
then prepared into stock solution (2.0 mg/mL) and further diluted with
CGM or DMEM accordingly. On the other hand, the positive control (5-
FU) was prepared by dissolving in DMSO, before making it into stock
solution (1.0 mg/mL) with CGM and diluted further accordingly. Using
PB-A and PB-B aqueous extract, investigation were carried out to ob-
serve PB compound proﬁle and anticancer eﬀects on malignant mela-
noma (A375).
2.3. Cell culture maintenance
A375 and NHDF cells were cultured in a CGM supplemented with
DMEM containing 10% Fetal Bovine Serum & 1% of penicillin strep-
tomycin antibiotic. These cells were maintained at 37 ℃ in 5% CO₂
humidiﬁed atmosphere.
2.4. Cell viability assay
This assay was carried out to screen the PB aqueous extracts cyto-
toxic eﬀect on A375 and NHDF cell lines. Cell viability assay was done
to determine 50% inhibitory concentration (IC50), proliferation assay
and toxicity assay were evaluated by following Promega CellTiter 96®
AQueous Non-Radioactive Cell Proliferation assay as recommended by
the manufacture. In determining IC50, optimized seeding density of
4× 102 cells/mL were treated with PB-A and PB-B at diﬀerent con-
centrations (3.9–1000 μg/mL) in 96-well plate and incubated for 72 h.
The colorimetric assay was measured at 490 nm using a microplate
reader (inﬁnite®Pro200 TECAN Group Ltd, Switzerland). The IC50 va-
lues of both PBs and 5-FU were calculated using Graphpad Prism 6.
Calculated IC50 of PB-A and PB-B values were used to test toxicity on
NHDF and A375 proliferation at 24, 48, 72 and 96 h. Both assays used
MTS calorimetric assay. Untreated (UT) cells were used as negative
control and 5-Fluorouracil was used as a positive control.
2.5. Cell cycle arrest assay
Cell cycle assay was performed in order to determine whether both
PB aqueous extract may induce cell arrest however, through which
phase. Grown cells were treated with PB-A and PB-B at IC50 for 72 h. All
cells from the well were collected and prepared in triplicate. The cells
were ﬁxed with cold ethanol for 2 h and stained with cell cycle kit. Cells
were analyzed using guava ﬂow cytometer.
2.6. Apoptosis assay
Apoptosis Annexin V/7AAD assay was performed to determine the
apoptosis distribution. A375 cells were treated with IC50 of PB-A and
PB-B for 72 h. All cells from the well were harvested and prepared in
triplicate. For apoptosis analyses, cells were stained using Nexin re-
agent (Millipore, USA) and analyzed using guava ﬂow cytometer
(Merck Millipore, USA). Distribution of early and late apoptotic cells
after exposure with both PBs was reported in dot plot graph.
2.7. Migration assay
The 2D migration assay was performed to determine the suppressive
eﬀect of PB-A and PB-B on migration of melanoma cells. A375 cells
were seeded in a 6-well plate for 24 h as described previously by Liang
et al. [20]. Once cells got attached, cells were scratched with 100mL
pipette tip and washed with PBS to remove non-adherent cells. Both
PBs, 5-FU and media for UT were added in each well accordingly.
Photomicrographs of migrated A375 were captured in using an inverted
microscope and the distance of cells closure was analysed using Image J
software.
2.8. Invasion assay
The aim of invasion assay was to evaluate the ability of PB-A and
PB-B in inhibiting A375 cells from invading the matrigel layer and
migrate passing through the inserts to lower chamber. Cell invasion
assay of A375 was done according to the manufacturer’s instructions
and as described previously by Berens et al. [21]. Matrigel was diluted
into 0.2mg/mL and pre-coated inserts with 8 μm pores. A375 cells were
serum starved for 6 h before trypsinized and seeded (2.0× 103 cells/
well) in upper chamber of inserts. Both PBs dissolved in serum free
media was added into upper chamber. Media with 2% of serum was
used as chemoattractant in lower chamber. Once 18 h of incubation was
achieved, cells which had invaded matrigel were ﬁxed with 4% paraf-
ormaldehde and stained with 0.2% crystal violet. Photomicrographs of
A375 treated with PB-A, PB-B, 5-FU, UT and uncoated were taken using
inverted microscope. Cells were manually counted in 6 random pho-
tomicrographs to calculate the percentage of invaded cells.
=
×
Invasion percentage Number of cells invadedmatrigel through insert
Number of cellsmigrated through uncoated insert
100%
2.9. Real time quantitative PCR (RT-qPCR) analysis
The aim of this assay was to quantify the mRNA expression of mRNA
of targeted primers related to apoptosis, cell cycle arrest and metastasis.
Total RNA was extracted from PB-A and PB-B treated or untreated A375
cells after 72 h using RNA extraction kit according to manufacturer’s
instructions. The RNA’s quality and integrity were assessed before
quantiﬁcation process. The complementary DNA (cDNA) was prepared
using cDNA synthesis kit according to manufacturer’s instructions.
200 ng of RNA template was synthesized into cDNA and later diluted in
the experiments. The primers were chosen from National Center for
Biotechnology Information (NCBI) database with a melting temperature
(Tm) of 59–65 °C. Amplicon size was 70–150 bases. Forward and re-
verse primers spanning exon-exon junctions were selected to avoid
ampliﬁcation of genome sequences. PCR ampliﬁcations were performed
using SYBR green in CFX96 Touch™ Real-Time PCR. Annealing tem-
perature was optimized using gradient temperature setting. Melting
curves were analysed to ensure ampliﬁcation speciﬁcity and null
primer-dimer formation. Primer PCR eﬃciency was evaluated using
serial dilutions of cDNA sample (1:10, 1:100, 1;1,000, 1:10,000 and 1:
100,000) in CFX Manager software. The ampliﬁcation eﬃciency (E)
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and correlation coeﬃcients (r2) of the standard curve ranging from
93.0% to 114.7% and 0.984 to 0.998 respectively. Details information
about the primers is attached in supplimentary 1. The ampliﬁcations
were done by following the conditions viz., 2 min at 50 °C, 10min at
95 °C, and 45 cycles of 15 s at 95 °C and 1min at 60 °C. Results were
analyzed using CFX Manager Software based on the threshold cycle
(CT) values. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and
β-actin (ACTB) were used as reference genes. The genes used and the
nucleotide sequences are summarized in supplementary 1.
2.10. Zebraﬁsh husbandry
Zebraﬁsh were bred and maintained in the Centre of Research and
Animal Management, International Islamic University Malaysia,
Malaysia. The zebraﬁsh were maintained at 28 °C with 14 h/10 h light/
dark cycle. The spawning took place with ratio of 4:2 male to female.
The fertilized embryos were collected at 3 hpf, cleaned with egg water
(0.2 g/L ocean salt in distilled water with 1 ppm methylene blue).
2.10.1. Zebraﬁsh toxicity evaluation
The aim of zebraﬁsh toxicity assay was to evaluate PB-A and PB-B
eﬀect on the median lethal concentration (LC50). The assay were per-
formed according to the ﬁsh embryo toxicity test guidelines with slight
modiﬁcations [22]. Brieﬂy, embryos at 3 hpf were randomly selected
and transferred into 300 μL PB-A and PB-B diluted with egg water. The
concentration tested was optimized to ensure the range concentation
tested induce 100% mortality and 100% alive. The embryos were ex-
posed with PB-A of 0.25, 0.5, 0.75, 1.0 and 1.25mg/mL while PB-B of
3.9, 7.8, 15.6, 31.25,62.5, 125, and 250 μg/mL for 96 h with egg water
as negative control. Twenty embryos were used for each group, and the
assay was repeated three times. The mortality was observed and cal-
culated which later analysed with Graphpad Prism software.
2.10.2. Antiangiogenesis assay
The aim of the assay was to evaluate whether PB-A and PB-B could
inhibit intersegmental vessels (ISVs) blood vessel formation. The assay
was performed as described previously. Brieﬂy, twenty healthy em-
bryos at 24 hpf (21 somite stage) were randomly selected and treated by
incubating in embryo water containing PB-A (1.25, 0.75 and 0.25mg/
mL), PB-B (125, 31.25 and 7.8 μg /mL), together with untreated as
negative control [23]. After treatment for 72 h of exposure, embryos
were returned to normal egg water. Later, embryos were collected and
ﬁxed overnight at 4 ℃ with 4% paraformaldehyde. Then, the embryos
were dehydrated with methanol, rinsed with PBST, and equilibrated
with NTMT(100mM Tris pH 9.5, 100mM NaCl, 50mM MgCl2, 0.1%
Tween- 20). The staining reaction was started by incubating embryos
with NBT/BCIP solution for about 15–30min according to the protocol.
After staining was completed, the embryos were washed with PBST.
Each embryo images were taken under inverted microscope. The
number of ISV for both PBs treated and UT were manually counted. The
percentage of ISV inhibition were calculated as describe previously [24]
= − ×
N UT ISV
ISV inhibition% 1 N(PB ISV)
( )
100%
2.11. Gas chromatography mass-spectroscopy (GCMS) proﬁle of porcupine
bezoar extracts
There is no reference available in the literature on porcupine bezoar
chamical proﬁle, hence the purpose of this assay was to examine the
grassy PB-A and PB-B proﬁle. Both PBs were derivatized as described
previously by Javadi et al. [25]. GCMS-TQ8030 linked to a GCMS-QP
2010 Plus Shimadzu gas chromatograph equipped with a capillary
column DB-5 (0.25 μm thickness× 0.25mm diameter× 30mm length)
was used for compound identiﬁcation. Helium (1.0 mL/min) was used
as the carrier gas. The instrument was operated in electron impact
mode at ionization voltage (70 eV), injector temperature (250 °C), and
detector temperature (280 °C). The starting oven temperature was set at
50 °C and held for 5min. This temperature was then programmed to
150 °C at 5 °Cmin and held for 5min. Finally, the temperature was
programmed to 300 °C for 5min at a rate of 5 °Cmin. The compounds
identiﬁcation from the spectral data was based on the available mass
spectral records in NIST database.
2.12. Statistical analysis
All values were presented as mean ± SD of triplicate from three
diﬀerent experiments (n= 3). A one-way analysis of variance (ANOVA)
was performed using the Prism statistical software package (GraphPad
Software, USA). Diﬀerences between PB-A and PB-B treated with UT
were considered signiﬁcant at p<0.01.
3. Results
3.1. Porcupine bezoar extract inhibited cell growth of A375
To evaluate the cytotoxic eﬀect of PBAE on human melanoma, A375
cells and NHDF cells were used in this study. Various concentrations of
PB-A and PB-B were treated on A375 cells and analysed using MTS
assay. PB-A and PB-B demonstrated a dose dependent inhibitory eﬀect
on A375 cells growth. The IC50 values of both PB have been reported
together with 5-FU in Fig. 2(a). The IC50 values of both PBs on human
breast cancer cell (MCF-7) and human cervical cancer cell (HeLa) is
attached in supplimentary 2.
The cytotoxic eﬀect of IC50 of PB-A and PB-B were further analyzed
through proliferation assay. The result in Fig. 2 (b) revealed that both
PB-A and PB-B inhibits cell growth signiﬁcantly across time incubation
when compared to UT. Using the same IC50 value of PB-A and PB-B,
cytotoxicity study was conducted on NHDF cells. Fig. 2 (c) displays PB-
A and PB-B eﬀect on NHDF after exposure for 72 h. The ﬁnding shows
PB-A and PB-B showed no signiﬁcant toxicity eﬀect towards NHDF cells
(normal cells). The ﬁnding was supported by morphological examina-
tion at 72 h of incubation. In Fig. 2 (d), A375 cells treated with the PB-A
and PB-B displayed reduced cells density when compared to UT and
presence of cells debris. PB-A and PB-B treated on NHDF showed no
signiﬁcant toxic eﬀect as the cells morphology was intact.
3.2. Porcupine bezoar extracts induced cell cycle arrest and apoptosis
Subsequently, the study investigated the connection of A375 cell
growth inhibition with cell cycle arrest. A375 cells were exposed with
PB aqueous extract treatment for 72 h and analyzed the cell cycle dis-
tribution using ﬂow cytometry. As depicted in Fig. 3 (a and b), PB-A
and PB-B induced signiﬁcant cells arrest in G2/M with the evidence of
signiﬁcant decreasing of cells proportion in G1/G0 phase by 36.4%(PB-
A), 37.5%(PB-B), increasing of cells proportion in G2/M phase by
50.4%(PB-A), 48.1%(PB-B) compared to UT 44.5% and 37.6%, re-
spectively. Expression of key genes involved in G2/M phase transition
was further investigated to elucidate the mechanism using qPCR in
Fig. 3 (c). The ﬁndings showed that both PBs had signiﬁcant eﬀect by
down-regulating the expression of CDK1 and cyclin B1 relative to
control. The mRNA expression indicated that PB-A and PB-B induced
G2/M arrest by inhibiting cyclin B1/CDK1 complex. Both PBs shows
down-regulating of cyclin B1 0.4 fold, 0.5 fold and CDK1 by 0.37 fold,
0.62 fold for PB-A and PB-B respectively.
Further analysis was carried out to evaluate whether PB-A and PB-B
inhibits the cells growth of A375 cells due to apoptotic activity. For this
reason, both PBs treated cells were stained with Annexin V/7AAD. As
displayed in Fig. 3 (d and e), both PBs induced apoptosis resulting in
signiﬁcant distribution of early apoptosis in PB-A and PB-B treatment
for 72 h. Dot plot graph in Fig. 3 (d) demonstrates that PB-A and PB-B
induced early apoptosis by 44.31% and 40.51% while for late apoptosis
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by 4.66% and 10.32% compared to UT which were 3.06% and 0.75%,
respectively. Fig. 3 (e) reveals bar graph proportions for PB-A of
apoptotic cells (including early and the late apoptosis) and live cells
which are 48.5% and 52.5%, while PB-B 50.8 and 49.2 respectively. To
understand the mechanism of apoptosis at molecular level, qPCR ex-
periment was performed on key gene viz. Bax (pro-apoptosis), Bcl2
(anti-apoptosis), cyto C(cytochrome C family), cas 3 and cas 9 (caspases
family). Fig. 3 (f) displays PB-A signiﬁcantly down-regulated Bcl2 (0.3
fold), up-regulation of Bax (1.7 fold), cyto C (3.1 fold), cas 3(4.4 fold)
and cas 9 (2.6 fold). PB-B shows similarly eﬀect by down-regulated Bcl2
(0.5 fold), up-regulated Bax by (2.9 fold), cyto c by (3.0 fold), cas 3 by
(2.2 fold), and cas 9 by (4.6 fold). The mRNA expression result sug-
gested that both PBs induces apoptosis via mitochondria apoptosis
pathway.
3.3. Porcupine bezoar extracts anti metastatic eﬀects on A375
The PB ability to inhibit migration and invasion was evaluated using
wound healing assay and transwell membrane assay. A 2D migration
assay was followed to determine the eﬀect of PB-A and PB-B on in-
hibition of A375 cells migration. Results in Fig. 4 (a and b) demonstrate
photomicrographic images of A375 cells PB-A, PB-B treated with UT
Fig. 2. Eﬀect of PB-A and PB-B on A375 and NHDF cells viability. a) Median concentration of A375 treated with PB-A, PB-B and 5-FU. Graph shown are after the
exposure with treatment for 72 h. IC50 are presented in mean ± SD (n=3). b) Anti-proliferative eﬀect of PB-A and PB-B at 24, 28, 72, 96 h with UT and 5-FU as
control. c) Cytotoxicity of PB-A and PB-B against NHDF cells at 72 h exposure. Results are presented in mean ± SD (n= 3). d) Image of A375 cells and NHDF upon
treated with PB-A, PB-B, UT and 5-FU for 72 h. Bar graph= 15 μm. * indicates p < 0.01.
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and 5-FU as control taken at 24 h. The results in Fig. 4 (b) demonstrate
that PB extract eﬀectively inhibited wound closure as percentage cells
migrated are 43.2% for PB-A and 57.3% for PB-B when compared to UT
which is 85.0%. Similar results were obtained in transwell invasion
assay shown in Fig. 4 (a and c). The transwell invasion assay evaluated
PB-A and PB-B treated A375 cells to invade the matrigel into lower
chamber using 2% FBS as chemoattractant. The ﬁnding revealed both
PBs inhibited the invasion signiﬁcantly by invading the matrigel 24.0%
(PB-A) and 26.9% (PB-B) compared to UT viz., 75.5%. Gene of matrix
metalloproteinases (MMP2 and MMP9), E-cadherin (an important
protein in formation of adherens junctions) and NM23 (the metastasis
suppressor) were investigated using qPCR. The mRNA expression
showed PB-A down-regulated signiﬁcantly MMP2 by 0.2 fold, MMP9 by
0.3 fold and signiﬁcantly up-regulated mRNA expression of NM23 and
E-cad by 4.5 and 4.1 fold, respectively (Fig. 4 (d)).Additionally PB-B
treated cells expressed similarly with PB-A it induce up-regulated in
NM23 (2.1 fold), E-cadherin (3.9 fold) and down-regulated MMP2(0.2
fold) and MMP9 (0.3 fold) signiﬁcantly. The ﬁnding suggested that PB-
Fig. 3. DNA histogram of PB-A and PB-B treated cells, with UT and 5-FU as control. The analysis was after 72 h of incubation. a) DNA histograms displays cells cycle
phases of treated cells namely G1/G0, S, and G2/M. b) The proportion of cells according to cell cycle phase are presented in percentage mean ± SD (n=3). The
modulations of mRNA expressions levels of targeted genes are expressed as relative gene expression based on the calculation using GAPDH and β-actin as the
reference gene, assigning the ratio in untreated cells as 1. Data are presented mean ± SD (n= 3). c) The mRNA expression of cell cycle targeted genes genes is
presented as relative gene expression mean ± SD (n= 3). d) Dot plot distribution of early and late apoptosis of A375 cells upon exposure with both PBs for 72 h with
UT and 5-FU as control. e) The proportion percentage of apoptotic (early and late apoptosis) and live cells are presented as percentage mean ± SD (n=3). f) The
mRNA expression of apoptosis targetted genes is presented as relative gene expression mean ± SD (n= 3). * indicates p < 0.01.
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A and PB-B inhibits melanoma cells migration and invasion.
3.4. Porcupine bezoars eﬀect on embryotoxicity of zebraﬁsh
This assay was aimed to determine the concentration which may
induce 50% mortality to embryos tested at end of the assay with 6
groups of concentration of PB-A, PB-B together with UT as negative
control. The ﬁnding revealed both PBs exhibited mortality on embryos
in dose-dependent manner. The log concentration against probits graph
is reported in Fig. 5 (a). The LC50 value at 96 hpf were found to be
450.0 ± 2.5 μg/mL and 58.7 ± 5.0 μg/mL for PB-A and PB-B respec-
tively. Additionally, morphology of UT embryo at 96 hpf showed no
sign of malformation. Contrary for PB-A, at 1.25mg/mL, Fig. 5 (b)
depicts that PB-A treated embryo showed delayed growth (72 hpf),
pericardial edema, yolk sac edema, swim bladder missing, intestine
malformation and heart malformation. The embryo treated with
Fig. 4. Anti-metastasis eﬀect of PB-A and PB-B against A375 cells. a) Photomicrographic image of A375 cells upon treatment with PB-A, PB-B, UT and 5-FU were
taken at 24 h for migration assay. The images of A375 cells invaded matrigel in transwell membrane to lower chamber with UT and 5-FU as control are hown as well
in (a). Bar graph= 25 μm. b) Graphical representation of migration percentage of A375 cells upon both PBs treatment is presented as percentage mean ± SD
(n=3). c) Percentage of A375 invasion upon treatment is presented as percentage mean ± SD (n=3). The modulations of mRNA expressions levels of targeted
genes are expressed as relative gene expression based on the calculation using GAPDH and β-actin as the reference gene, assigning the ratio in untreated cells as 1. d)
MRNA expressions of targeted genes related to metastasis are presented as mean ± SD (n= 3). * indicates p < 0.01.
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0.75mg/mL PB-A showed malformation of delayed growth (72 hpf),
pericardial edema, yolk sac edema and swim bladder missing. However,
the embryo treated with 0.25mg/mL displayed only slightly delayed
growth with malformation of swimming bladder. PB-B was more potent
in inducing toxic eﬀect compared to PB-A. The highest concentration
observed for toxicity of PB-B was 125.0 μg/mL, where it caused growth
delayed, missing swimming bladder, large yolk sac, and slightly peri-
cardial edema. PB-B 31.2 μg/mL induced delayed growth, missing
swimming bladder and yolk sac malformation. However, lowest con-
centration 7.8 μg/mL reported to have only growth delayed without
other type of malformation. The ﬁnding shows PB-A induced more
malformation compared to PB-B.
3.5. Porcupine bezoars eﬀects on angiogenesis of embryo zebraﬁsh
Cancer angiogenesis plays major role in cancer metastasis. Hence,
PB-A and PB-B potential as antiangiogenesis agent was further vali-
dated through in vivo angiogenesis zebraﬁsh model. The treated PBs
embryos were evaluated for their eﬀect on ISV formation. Three con-
centrations of PB-A were used to observe angiogenesis of ISVs viz., 1.25,
0.75 and 0.25mg/mL.While for PB-B 125.0, 31.2, and 7.8 μg/mL were
used. The ﬁnding in Fig. 6 (a) and (b) revealed control embryo at the
Fig. 5. PB’s eﬀect on embryo zebraﬁsh. a)The median lethal concentration of PB-A and PB-B. Assay was performed triplicate with n= 20 for each group, result
presented as probit ± SD. b) Representative of PB-A treated embryo for embryotoxicity assay. c) Representative of PB-B treated embryo for embryotoxicity assay.
Three concentration was chosen for morphological observation of both PBs treated on embryos with untreated was consider as negative control. Bar
Graph=200 μm. The swimming bladder (SB), yolk sac (YC), pericardial edema (PE) and intestine malformation (IN). Three separate assay was perform with n= 20.
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end of assay displayed well sprout ISVs, lumenized with arranging
array. On the other hand, PB-A was found to inhibit blood vessel for-
mation in dose dependent manner as it signiﬁcantly inhibit the vascu-
lature formation by 90.4%, 73.3% and 45.0% at 1.25mg/mL, 0.75mg/
mL and 0.25mg/mL, respectively. Similar eﬀect found in PB-B where it
found to inhibit vasculature formation by 91.4%, 76.4% and 9.5% at
125.0 7.8 μg/mL, 31.2 7.8 μg/mL, and 7.8 μg/mL respectively.
3.6. Porcupine bezoars aqueous extract GC–MS chemical proﬁle
The chromatogram of PB-A and PB-B is shown in Fig. 7 and Table 1
presents the compound for each major peak in the chromatogram.
Table 1 displays both PB aqueous extract’s compounds with their,
molecular formula, peak percentage and probability index. The GC–MS
analyses of PB-A revealed major components namely dilauryl thiodi-
propionate (47.27%), pentadecyl acrylate (10.36%), 5,10-Diethoxy-
2,3,7,8-tetrahydro-1H,6H-dipyrrolo[1,2-a:1′,2′-d]pyrazine (9.11%) and
lauryl 3-mercaptopropionate (7.24%). On the other hand, PB-B major
components revealed 5,10-Diethoxy-2,3,7,8-tetrahydro-1H,6H-di-
pyrrolo[1,2-a:1′,2′-d]pyrazine (11.28%), Ursodeoxycholic acid
(8.63%), Cholest-5-en-3-ol (3.beta.)-, carbonochloridate (7.25%), Pen-
tadecyl acrylate (4.10%) and Stearic acid (3.50%). The compounds
Fig. 6. PB’s eﬀect on embryo angiogenesis zebraﬁsh assay. a) Graph representation of ISV inhibition percentage for treated PB-A and PB-B embryos. Assay was
performed thrice with n= 20 for each group, result presented as percentage mean ± SD. * indicates p<0.01. b) Representative of angiogenesis assay of PB-A. b)
Representative of angiogenesis assay of PB-B. Three concentration viz. 1.25, 0.75, 0.25mg/mL of PB-A and 125.0, 31.2, 7.8 μg/mL were treated on embryos with
untreated considered as negative control. Bar graph=150 μm. The red arrows indicate complete ISV. (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article).
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structures and mass spectrum for each compound are reported in a
supplimentary 3 ﬁle.
4. Discussion
Melanoma is one of the deadliest malignant skin cancers with high
incidence and drugs resistance. Therefore, potential anticancer agents
with minimal toxicity are considered promising candidates. In this
study, two PB aqueous extract namely PB-A and PB-B were assessed for
its in vitro and in vivo potency as an anticancer agent against A375 cells
and zebraﬁsh, respectively. The median inhibition concentration assay
revealed low concentrations for both PB needed to inhibit 50% of A375
cells growth at 72 h. However, further analysis demonstrated that both
PB exhibits cytotoxic and cytostatic capacity in a dose and time de-
pendent manner. Challenge with chemotherapy and other current drugs
despite the ability to kill cancer cells also is to kill normal cells sur-
rounding the cancer as well [11,26]. Hence, cytotoxicity on normal cell
is an important aspect of this study which sought to determine the eﬀect
of PB-A and PB-B on normal cell lines (NHDF). The assay revealed that
PB-A and PB-B did not pose any signiﬁcant toxicity towards NHDF
compared to 5-FU which is a standard anticancer agent. Additionally,
the morphology of both PBs treated cells showed apoptosis signs
comprising cells shrinkage, cytoplasm rounding, presence of cells debris
and reduction in cells viability numbers which are hallmark of apop-
tosis [27].
Cells cycle analysis was conducted to understand the mechanism of
anti-proliferation eﬀect of PBs. The results indicated that PB-A and PB-B
arrested G2/M phase in A375 by down regulating mRNA expression of
cyclin B1 and CDK1 which are crucial in forming cyclin B1/CDK 1
complexes. The inhibition resulted in preventing A375 cells from en-
tering mitosis phase and arrested in G2 phase for either recovery or
apoptosis [28]. However 5-FU in this study reported to arrest A375 cells
in G1/S phase. Previous study reported similar study where 5-FU arrest
Human laryngeal squamous cancer cells(UMSCC11 A and UMSCC12)
by increasing retinoblastoma (pRb) tumor suppressor protein and de-
creasing cyclin E expression [29]. Furthermore, the ability of PBs to
induce apoptosis was evaluated using apoptosis Annexin V/AAD assay.
In analysing the apoptosis, the cells were categorised in quadrants base
in the presence or absence of phosphatidylserine and 7-AAD detection
which help in diﬀerentiating early, late apoptotic and necrotic cells
[30]. The ﬁnding showed both PBs induced apoptosis when compared
to UT cells and 5-FU treated cells. The underlying mechanism of
Fig. 7. The chromatogram of GC–MS proﬁle for both PBs used in this study. a)PB-A and b) PB-B.
Table 1
GC–MS spectral analysis of compound presents in both PB-A and PB-B.
Peak Compound Retention time Molecular formula Peak (%) PB-A Peak (%) PB-B Probability Index
1 1-Dodecanol 9.755 C12H26O 2.54 2.91 97
2 Pentadecyl acrylate 12.53 C18H34O2 10.36 4.10 91
3 5,10-Diethoxy-2,3,7,8-tetrahydro-1H,6H-dipyrrolo[1,2-a:1',2'-d]pyrazine 15.554 C14H22N2O2 9.11 11.28 91
4 Lauryl 3-mercaptopropionate 16.110 C15H30O2S 7.24 2.32 93
5 Stearic acid 17.812 C18H36O2 2.52 3.50 90
6 Dilauryl thiodipropionate 23.258 C30H58O4S 47.27 2.56 78
7 Pregnenolone 25.542 C21H32O2 1.25 2.73 85
8 Cholest-5-en-3-ol (3.beta.)-, carbonochloridate 29.276 C28H45ClO2 2.21 7.25 80
9 Ursodeoxycholic acid 33.437 C24H40O4 2.37 8.63 83
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apoptosis induction was investigated at molecular level using qPCR
analysis. The mRNA expressions of PBs treated indicated apoptosis
occurs via mitochondria apoptosis pathway. The intrinsic pathway is
initiated within cells involving the Bcl2 families such as pro-apoptosis
(Bax) and anti-apoptosis (Bcl2) genes to regulate the promotion or in-
hibition of apoptosis [31]. PBs also found to up-regulate the expressions
of cytochrome C, caspase 9 and caspase 3. The ﬁnding was found to be
in line with intrinsic pathway in which internal stimuli induce bax to
activate cytochrome C release into cytosol and activate caspase cascade
through caspase 9 and caspase 3 [32–34]. Additionally, it has been
reported that 5-FU induces apoptosis through perforin/granzyme
pathway which is diﬀerent from PB pathway, hence, explains the
mRNA expression which is contrary to PBs mRNA expression [35].
Another study reported 5-FU induced its anticancer eﬀects by inhibiting
thymidylate synthase (TS) and incorporation of its metabolites into
RNA and DNA which lead to DNA damage [36].
Although there are many anticancer drugs available to inhibit
cancer growth, less number of drugs available to inhibit metastasis of
cancer [37]. Melanoma is highly invasive and metastatic in nature,
hence in this study, the migration and invasion of PB-A and PB-B
treated A375 cells were evaluated. Metastasis consists of multi-step
process involving adhesion of cells, invasion and migration [38].
Therefore, intervention in any of the steps is considered the key factor
to inhibit metastasis progression. The ﬁnding suggested for both PBs to
be able to suppress A375 cells migration and matrigel invasion hence
signiﬁes its potential as an anti-metastasis agent. Matrix metallopro-
teinases (MMPs) play roles in degradation of extracellular matrix (ECM)
components and the MMPs which contribute in metastasis are MMP2
and MMP9 [39]. Thus down-regulation of MMP 2 and MMP 9 indicates
inhibition degradation of ECM. Additionally, E-cadherins up regulation
indicated invasion was hinder as cadherins play important roles in cell
adhesion where it knits together at the intercellular junction through
dissociating from its neighbour. Hence increasing E-cadherin genes,
showed A375 invasion inhibited [40]. NM23 is also known as metas-
tasis suppressor which play a key role in metastasis, hence up regula-
tion of NM23 genes in PB-A and PB-B treated cells suggested that A375
cells were suppressed from migrated and invaded [41,42].
The embryo zebraﬁsh model was considered the most suitable an-
imal model in this study as it mimics the physiology of mammals, rapid,
fast and eﬃcient screening with less usage of [42–44]. The embryo
toxicity assay revealed PB-A exerted signiﬁcant toxicity on embryos
only at high concentration, whereas at low concentration PB-A exerted
delayed growth. However, PB-B LC50 exert signiﬁcant toxicity eﬀects at
low concentration, indicating PB-B was more toxic compared to PB-B.
This ﬁnding is crucial as people generally consume PB by infusing it
into water for hours until it tastes bitter or sometimes take certain
amount orally without even realising about the dose taken and its
toxicity eﬀect. Additionally, it is revealed each PB has diﬀerent level of
toxicity level. Hence, further evaluation should be done to understand
the toxicity eﬀects of bezoar. The angiogenesis is an essential phase for
tumor progression and spreading to other parts of body [45]. Hence,
this study investigates PBs eﬀect on antiangiogenesis in vivo to further
conﬁrm its anticancer potential. The angiogenesis assay using embryo
zebraﬁsh is considered the feasible animal model as conventional in
vitro assay lacks the biological complexity of blood vessels and common
in vivo model such as chick chorioallantoic membrane assay requires a
large quantity of extract are the major drawback for PB extract [44,46].
The PB-A extracts revealed to have antiangiogenic potential at all
concentrations tested even at 250 μg/mL which is lower than the LC50
reported in this study. PB-B as expected shown anti-angiogenic eﬀects
as well at all concentration but the assay revealed PB-A shown to be
more potent in exerting the antiangiogenic eﬀects as at 31.25 μg/mL it
inhibit more than 76.4% which is more lower than the LC50 of PB-
B.Moreover, it can be deduced that the antiangiogenic eﬀect also aﬀects
the growth of the embryos which further explains the growth delayed in
the embryo toxicity assay.
Gas chromatography-mass spectrometry analysis was performed to
determine the chemical proﬁle of PB-A and PB-B. Compounds identiﬁed
were present in both PB-A and PB-B. Previous study reported stearic
acid and ursodeoxycholic acid compounds possessed an anticancer ac-
tivity [47,48]. Additionally stearic acid and ursodeoxycholic acid
compounds are found to be major compound in calculus bovis (cow
bezoar) as well [49]. Stearic acid is found primarily in animal deriva-
tives and plant fat where it is mainly used as dietary and cosmetics
[50–52]. Stearic acid reported to induce apoptosis in MDA-MB-231
through mitochondria pathway by reducing mitochondria membrane
potential [53,54]. Ursodeoxycholic acid is a synthetic bile acid which
reported used for treatment of gallstones and primary biliary cirrhosis
[55]. Additionally the ursodeoxycholic acid reported exhibited antic-
ancer properties by inhibit cells proliferation through regulation of
oxidative stress in colon cancer cells [48,56]. Moreover, ursodeoxy-
cholic acid had high capacity to scavenge hydroxyl and lipid perox-
idation antioxidant assays [57]. Another compound detected in both
PBs is pregnenolone. Pregnenolone is a precursor for the synthesis of
corticoids and androgens, and it displays neuroactive properties [58].
Pregnenolone revealed to had anti-cancer activity against hepatocel-
lular carcinoma cell line (HepG2) by inducing apoptosis through DNA
fragmentation [59]. Furthermore among detected compounds, dilauryl
thiodipropionate has been reported to be used as food additive for its
secondary antioxidant properties in the food industry [60]. Previous
study reported pentadecyl acrylate, have DPPH and ABTS antioxidant
activity [61]. However remaining compounds have no previous study
related to any biological activity.
The bezoars are formed from reaction of undigested porcupine food
and enzymes from porcupine itself. Additionally, it is crucial to un-
derstand that each PB is unique and comes from diﬀerent porcupine.
Moreover, the food habbit of individual porcupine might also diﬀer
from one another that may also contribute for diversed chemical proﬁle
among bezoars. Furthermore, the age of the bezoar in porcupine and
location of the bezoar collected could also play major roles for the
diﬀerent chemical proﬁle and quantity of the compounds in bezoars.
Hence, support strong possibility of varried biological eﬀects amongst
bezoars obtained from diﬀerent porcupines.
5. Conclusion
The ﬁndings in this study are the ﬁrst to report two PB aqueous
extract (PB-A and PB-B) exhibits anti-melanoma properties. Both PBs
aqueous extract showed that it could inhibit cells migration, invasion
and angiogenesis possibly through cell growth inhibition, arrest cell
cycle in G2 phase and induction of apoptosis via mitochondria
pathway. Most importantly, PB-A and PB-B extract possesses anticancer
properties without signiﬁcant toxicity on normal cells. Therefore, this
study suggests that PB is a potential agent for inhibiting melanoma
growth and metastasis.The GCMS proﬁle revealed PB-A and PB-B have
same compound presents in both PB. Stearic acid, ursodeoxycholic acid
and pregnenolone compounds may be responsible for the anticancer
eﬀect of PB extract. However, other unidentiﬁed compounds which
were not present in the library of the GC–MS system could not be
identiﬁed from their accurate mass, may also play some roles towards
its anticancer eﬀect. Hence, further research is still needed to obtain
such bioactive compounds in pure form for complete pharmacological
evaluations as anticancer agents. Moreover, further analysis involving
higher vertebrae in vivo models should also be done to understand the
PB eﬀects in living organism more meticulously as well as its identiﬁed
compounds as anticancer agents.
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